WHO ICTRP trial
Ultrasound contrast agents to facilitate sonothrombolysis in patients with acute…
NL-OMON39042 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON39042 |
|---|---|
| Public title | Ultrasound contrast agents to facilitate sonothrombolysis in patients with acute myocardial infarction |
| Scientific title | Ultrasound contrast agents to facilitate sonothrombolysis in patients with acute myocardial infarction - Sonolysis study |
| Primary sponsor | Vrije Universiteit Medisch Centrum |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Countries | Netherlands |
| Conditions | acute myocardial infarction;10011082;10003216;acute myocardial infarction |
| Interventions | Immediately before treatment with primary PCI, patients presenting with an STEMI will be randomized to undergo intravenous infusion of an UCA and diagnostic ultrasound or saline, both for 15 minutes ;acute myocardial… |
| Registration date | Jul 4, 2013 |
| Target size | 60 |
| Secondary IDs | ISRCTN32486185;NL40613.029.13 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: